LABSCO Receives Innovative Technology Designation from Vizient for LABSCO SD2 – Software Delive

Designation recognizes the development of new solutions that benefit the health care industry
By: LABSCO - Delivering Superior Diagnostics
 
LOUISVILLE, Ky. - Feb. 3, 2016 - PRLog -- (LOUISVILLE, KY) – December 16, 2015– LABSCO announced its LABSCO SD2 solution has received Innovative Technology designation from Vizient, Inc. (https://vizientinc.com/) the largest member-owned health care company in the country.  The designation was based on reviews of LABSCO SD2 by hospital experts who attended Vizient’s Innovative Technology Expo in November. The annual event provides medical technology suppliers the opportunity to demonstrate their product and gain direct feedback from onsite clinical experts and health care providers on the impact their products may have on improving clinical care, safety, or benefits to organization’s care and business models.

LABSCO SD2 (Software Delivering Superior Diagnostics) is a highly flexible and customizable laboratory intelligence software and services package that enables clinical laboratories to easily realize the power of technology. LABSCO has developed the SMART TESTSTM autoverification design and implementation process, and partnered with Data Innovations® to give laboratories the ability to achieve autoverification rates of over 95% coupled with the ability to truly optimize laboratory processes, giving them the ability to grow and truly do more with less.  LABSCO SD2 enables laboratories to monitor and modify their processes and production with a best-in-class customizable business intelligence solution. LABSCO SD2 also offers customizable options, enabling laboratories to optimize and control many common laboratory processes including: connectivity, equipment maintenance management, specimen archiving, LIS downtime alleviation, LIS migration assistance, and many more.  All LABSCO SD2 options come with expert installation and consultation assistance from leading industry experts with many years of experience.

“LABSCO Delivers Superior Diagnostics to community hospitals, large physician offices and specialty regional laboratories. LABSCO uniquely serves as an exclusive sales agent providing a best-in-class portfolio of laboratory solutions that improve lab efficiency and patient care by enhancing clinical, operational and financial outcomes. LABSCO SD2 enables our customers to achieve efficiency and quality exponentially above their current state. Customers are no longer bound by gaps within their current LIS (laboratory information system) or EMR (electronic medical record) and can take control over their results review process and data flow,” said Joel Weihe, Executive VP of LABSCO Marketing.

“We understand the challenges that lab directors and administrators face to deliver high quality diagnostic results quickly and efficiently. While testing volumes increase, the labor pool of qualified technologists is rapidly reducing and current systems continually fail to provide adequate solutions. Laboratories must improve operating efficiency and bottom line results with limited resources and capital, and can only do that through the right processes and technology.  LABSCO SD2 is being quickly adopted as an indispensable tool in many labs,” added Bill Marquardt, VP Lab Intelligence / Connectivity.

“Vizient is committed to providing the members we serve with leading-edge technologies that deliver new clinical and operational benefits from what is currently available in the market today,” said Debbie Archer, director of procurement and leader of the Innovative Technology program for suppliers. “After a reviewing LABSCO and SD2 TECHNOLOGY at our annual Innovative Expo, the hospital experts who attended agreed the product offers unique and incremental benefit over other products available on the market today, and recommended it for the Innovative Technology designation.”

Vizient is the new brand identity for the organizations formerly known as VHA Inc, UHC, and Novation. Since 2003, more than 2000 new and innovative products and technologies have been submitted through the Vizient Innovative Technology program. Vizient works with member-led councils and task forces to identify and review potentially innovative products. If it is determined that a product is innovative, a contract may be awarded outside of Vizient’s competitive bid cycle.

To learn more about Vizient’s Innovative Technology program, visit www.novationco.com/expertise/technology.

ABOUT LABSCO

LABSCO Delivers Superior Diagnostics, specializing in community hospital labs and POLs. LABSCO provides a best-in-class portfolio of laboratory solutions that improve lab efficiency and patient care by enhancing clinical, operational and financial outcomes.

LABSCO uniquely serves as: an exclusive sales agent with allies such as Siemens, Sysmex and BioFire, a specialty distributor for market-leading brands of ancillary capital equipment and a general distributor of private label and key brand partner supplies.

LABSCO sales force representatives are clinical laboratory experts in Chemistry, Immunoassay, Molecular, Hematology, Hemostasis, Blood Gas, Diabetes Care, Urinalysis, Point of Care, Lab Supplies and Lab Intelligence.

Learn more at LABSCO.com (http://cts.businesswire.com/ct/CT?id=smartlink&url=ht...)
End
Email:***@labsco.com Email Verified
Tags:LABSCO, Vizient, Hospital
Industry:Medical
Location:Louisville - Kentucky - United States
Subject:Partnerships
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
LABSCO News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share